Improvement of Refractory Chronic Actinic Dermatitis During Tofacitinib Treatment : American Journal of Therapeutics

Secondary Logo

Journal Logo

Letters to the Editor

Improvement of Refractory Chronic Actinic Dermatitis During Tofacitinib Treatment

Wang, Ying-Jun MM1,2; Hui, Hai-Zhen MM1,2; Cheng, Jia-Rong MM1,2; Mao, Han MM1,2; Diao, Qing-Chun MD1; Shi, Bing-Jun MD1

Author Information
American Journal of Therapeutics ():10.1097/MJT.0000000000001616, March 1, 2023. | DOI: 10.1097/MJT.0000000000001616
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid